DiaMedica Therapeutics DMAC
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 7.96 | 105.53 | -0.17 | -9,213 | -9 | |
| 2025Q3 | 6.87 | 104.86 | -0.17 | -9,033 | -9 | |
| 2025Q2 | 3.90 | 104.08 | -0.18 | -8,007 | -8 | |
| 2025Q1 | 3.79 | 105.75 | -0.18 | -8,144 | -8 | |
| 2024Q4 | 5.43 | 106.69 | -0.18 | -8,419 | -8 | |
| 2024Q3 | 4.19 | 109.83 | -0.15 | -6,883 | -6 | |
| 2024Q2 | 2.95 | 110.29 | -0.13 | -5,638 | -5 | |
| 2024Q1 | 2.77 | 111.61 | -0.14 | -5,741 | -5 | |
| 2023Q4 | 2.84 | 113.80 | -0.14 | -5,848 | -5 | |
| 2023Q3 | 2.58 | 115.52 | -0.10 | -5,157 | -4 | |
| 2023Q2 | 4.32 | 106.06 | -0.16 | -4,741 | -4 | |
| 2023Q1 | 1.53 | 104.86 | -0.20 | -5,521 | -5 | |
| 2022Q4 | 1.58 | 106.12 | -0.14 | -3,973 | -4 | |
| 2022Q3 | 1.24 | 102.49 | -0.12 | -3,128 | -3 | |
| 2022Q2 | 2.02 | 100.39 | -0.13 | -3,364 | -3 | |
| 2022Q1 | 2.50 | 101.00 | -0.13 | -3,536 | -4 | |
| 2021Q4 | 3.73 | 100.22 | -0.10 | -3,246 | -3 | |
| 2021Q3 | 4.01 | 99.22 | -0.18 | -3,416 | -3 | |
| 2021Q2 | 4.45 | 103.00 | -0.18 | -3,365 | -3 | |
| 2021Q1 | 9.15 | 100.11 | -0.19 | -3,619 | -4 |